The Relationship Between Mental Health and Drugs used in Dermatology
DOI:
https://doi.org/10.12775/JEHS.2024.56.014Keywords
mental health, psychiatric symptoms, drug side effects, drugs in dermatologyAbstract
INTRODUCTION: Dermatological diseases are a common clinical problem in medical practice. Various groups of medications are used in their treatment. Psychiatric disorders also present a significant challenge for modern medicine, some of them may have iatrogenic origins. This study analyzes drugs used in dermatological diseases and their impact on mental health.
REVIEW METHODS: This review of the literature collects data from PubMed and Google Scholar about medications used for treating dermatological conditions and their potential impact on mental health.
THE STATE OF KNOWLEDGE: Acyclovir, valacyclovir, chloroquine, hydroxychloroquine, tetracyclines, retinoids, glucocorticoids, 5-alpha-reductase inhibitors, dapsone and methotrexate are mentioned in the literature as possible, but rare causes of the onset /exacerbation of various psychiatric symptoms. Comparing to general population, patients with skin disorders suffer more often from depression and anxiety. Those two diseases are mentioned most frequently in the context of psychiatric side effect of drugs discussed in the article.
SUMMARY: Psychiatric side effects of drugs used in dermatology are not common. However, given the rising incidence of mental health disorders worldwide, it is important to be aware of them.
References
Simon, J., Boyer, P., Caldas-de-Almeida, J. M., Knapp, M., McCrone, P., Gorwood, P., Oertel, W., Arango, C., Treasure, J., Young, A. H., Destrebecq, F., & Quoidbach, V. (2023). Viewpoint: Assessing the value of mental health treatments in Europe. European psychiatry : the journal of the Association of European Psychiatrists, 66(1), e59. https://doi.org/10.1192/j.eurpsy.2023.
Malhi GS, Mann JJ. Depression. Lancet. 2018 Nov 24;392(10161):2299-2312.Malhi GS, Mann JJ. Depression. Lancet. 2018 Nov 24;392(10161):2299-2312. doi: 10.1016/S0140-6736(18)31948-2. Epub 2018 Nov 2. PMID: 30396512
https://www.ncbi.nlm.nih.gov/books/NBK559078/#
Flohr, C., & Hay, R. (2021). Putting the burden of skin diseases on the global map. The British journal of dermatology, 184(2), 189–190.
https://doi.org/10.1111/bjd.19704
Richard MA, Paul C, Nijsten T, Gisondi P, Salavastru C, Taieb C, Trakatelli M, Puig L, Stratigos A; EADV burden of skin diseases project team. Prevalence of most common skin diseases in Europe: a population-based study. J Eur Acad Dermatol Venereol. 2022 Jul;36(7):1088-1096.
https://doi.org/10.1111/jdv.18050
Karimkhani C, Dellavalle RP, Coffeng LE, et al. Global Skin Disease Morbidity and Mortality: An Update From the Global Burden of Disease Study 2013. JAMA Dermatol. 2017;153(5):406-412.
https://doi.org/10.1001/jamadermatol.2016.5538
Hahnel, E., Lichterfeld, A., Blume-Peytavi, U., & Kottner, J. (2017). The epidemiology of skin conditions in the aged: A systematic review. Journal of tissue viability, 26(1), 20–28. https://doi.org/10.1016/j.jtv.2016.04.001.
Cortés, H., Rojas-Márquez, M., Del Prado-Audelo, M.L., Reyes-Hernández, O.D., González-Del Carmen, M. and Leyva-Gómez, G. (2022), Alterations in mental health and quality of life in patients with skin disorders: a narrative review. Int J Dermatol, 61: 783-791.
https://doi.org/10.1111/ijd.15852
Balieva, F., Abebe, D. S., Dalgard, F. J., & Lien, L. (2023). Risk of developing psychiatric disease among adult patients with skin disease: A 9-year national register follow-up study in Norway. Skin health and disease, 3(6), e294.
https://doi.org/10.1002/ski2.294
Dalgard, F. J., Gieler, U., Tomas-Aragones, L., Lien, L., Poot, F., Jemec, G. B. E., Misery, L., Szabo, C., Linder, D., Sampogna, F., Evers, A. W. M., Halvorsen, J. A., Balieva, F., Szepietowski, J., Romanov, D., Marron, S. E., Altunay, I. K., Finlay, A. Y., Salek, S. S., & Kupfer, J. (2015). The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. The Journal of investigative dermatology, 135(4), 984–991. https://doi.org/10.1038/jid.2014.530
Jafferany, M., & Franca, K. (2016). Psychodermatology: Basics Concepts. Acta Dermato-Venereologica, 96(217), 35–37
https://doi.org/10.2340/00015555-2378
Gnann, J. W., Jr, Barton, N. H., & Whitley, R. J. (1983). Acyclovir: mechanism of action, pharmacokinetics, safety and clinical applications. Pharmacotherapy, 3(5), 275–283. https://doi.org/10.1002/j.1875-9114.1983.tb03274.x
Conan MacDougall, B. Joseph Guglielmo, Pharmacokinetics of valaciclovir, Journal of Antimicrobial Chemotherapy, Volume 53, Issue 6, June 2004, Pages 899–901, https://doi.org/10.1093/jac/dkh244
Paluch Z, Trojánek M, Velíšková Z, et al. Neurotoxic side effects of acyclovir: two case reports. Neuro Endocrinol Lett. 2021;42(6):375-382.
Sahoo, A., & Josephs, K. A. (2018). A Neuropsychiatric Analysis of the Cotard Delusion. The Journal of neuropsychiatry and clinical neurosciences, 30(1), 58–65. https://doi.org/10.1176/appi.neuropsych.17010018
Kassam, A. S., & Cunningham, E. A. (2018). Cotard Syndrome Resulting From Valacyclovir Toxicity. The primary care companion for CNS disorders, 20(1), 17l02143. https://doi.org/10.4088/PCC.17l02143
Bogaczewicz, Anna & Sobow, Tomasz. (2017). Psychiatric adverse effects of chloroquine. Psychiatria i Psychologia Kliniczna. 17. 111-114. https://doi.org/10.15557/pipk.2017.0012
Rodriguez-Caruncho C, Bielsa Marsol I. Antipalúdicos en dermatología: mecanismo de acción, indicaciones y efectos secundarios. Actas Dermosifiliogr. 2014;105:243–252.
Bogaczewicz, A., Sobow, T., Bogaczewicz, J., Bienkowski, P., Kowalski, J., & Wozniacka, A. (2016). Chloroquine-induced subacute paranoid-like disorder as a complication of dermatological treatment. International journal of dermatology, 55(12), 1378–1380.
https://doi.org/10.1111/ijd.13266
Markiewicz Z., Kwiatkowski Z.A., 2012. Bakterie, antybiotyki, lekooporność. Wydawnictwo Naukowe PWN, 2012 (copyright 2006)
Tetracyclinum TZFprescribing information (2023). Tarchomińskie Zakłady Farmaceutyczne „Polfa” Spółka Akcyjna, Warszawa
Essali, N., & Miller, B. J. (2020). Psychosis as an adverse effect of antibiotics. Brain, behavior, & immunity - health, 9, 100148.
https://doi.org/10.1016/j.bbih.2020.100148
Atigari, O. V., Hogan, C., & Healy, D. (2013). Doxycycline and suicidality. BMJ case reports, 2013, bcr2013200723.
https://doi.org/10.1136/bcr-2013-200723
Shamim MA, Manna S, Dwivedi P, et al. Minocycline in depression not responding to first-line therapy: A systematic review and meta-analysis. Medicine (Baltimore). 2023;102(45):e35937.
https://doi.org/10.1097/MD.0000000000035937
Szymański, Ł., Skopek, R., Palusińska, M., Schenk, T., Stengel, S., Lewicki, S., Kraj, L., Kamiński, P., & Zelent, A. (2020). Retinoic Acid and Its Derivatives in Skin. Cells, 9(12), 2660.
https://doi.org/10.3390/cells9122660
Nakamura, Mio & Sekhon, Sahil & Raymond, Amanda & Koo, John. (2018). Oral Retinoids in Dermatology.
https://doi.org/10.1007/978-3-319-66884-0_22
Khalil, S., Bardawil, T., Stephan, C., Darwiche, N., Abbas, O., Kibbi, A. G., Nemer, G., & Kurban, M. (2017). Retinoids: a journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects. The Journal of dermatological treatment, 28(8), 684–696
https://doi.org/10.1080/09546634.2017.1309349
Suuberg A. (2019). Psychiatric and Developmental Effects of Isotretinoin (Retinoid) Treatment for Acne Vulgaris. Current therapeutic research, clinical and experimental, 90, 27–31.
https://doi.org/10.1016/j.curtheres.2019.01.008
Li, C., Chen, J., Wang, W., Ai, M., Zhang, Q., & Kuang, L. (2019). Use of isotretinoin and risk of depression in patients with acne: a systematic review and meta-analysis. BMJ open, 9(1), e021549
https://doi.org/10.1136/bmjopen-2018-021549
Huang, Y. C., & Cheng, Y. C. (2017). Isotretinoin treatment for acne and risk of depression: A systematic review and meta-analysis. Journal of the American Academy of Dermatology, 76(6), 1068–1076.e9.
https://doi.org/10.1016/j.jaad.2016.12.028
Ludot, M., Mouchabac, S., & Ferreri, F. (2015). Inter-relationships between isotretinoin treatment and psychiatric disorders: Depression, bipolar disorder, anxiety, psychosis and suicide risks. World journal of psychiatry, 5(2), 222–227. https://doi.org/10.5498/wjp.v5.i2.222
Jensen, K. V., & Abba-Aji, A. (2020). Isotretinoin-Induced Delusional Disorder, Somatic Subtype. Case reports in dermatological medicine, 2020, 8853167. https://doi.org/10.1155/2020/8853167
Greaves, M., & Gatti, S. (1999). The use of glucocorticoids in dermatology. Journal of Dermatological Treatment, 10(2), 83–91.
https://doi.org/10.3109/09546639909056008
Hengge, U. R., Ruzicka, T., Schwartz, R. A., & Cork, M. J. (2006). Adverse effects of topical glucocorticosteroids. Journal of the American Academy of Dermatology, 54(1), 1–18.
https://doi.org/10.1016/j.jaad.2005.01.010
Manzo, C., Serra-Mestres, J., Castagna, A., & Isetta, M. (2018). Behavioral, Psychiatric, and Cognitive Adverse Events in Older Persons Treated with Glucocorticoids. Medicines (Basel, Switzerland), 5(3), 82.
https://doi.org/10.3390/medicines5030082
Judd, L. L., Schettler, P. J., Brown, E. S., Wolkowitz, O. M., Sternberg, E. M., Bender, B. G., … Singh, G. (2014). Adverse Consequences of Glucocorticoid Medication: Psychological, Cognitive, and Behavioral Effects. American Journal of Psychiatry, 171(10), 1045–1051.
https://doi.org/10.1176/appi.ajp.2014.13091264
Salisbury BH, Tadi P. 5-Alpha-Reductase Inhibitors. [Updated 2023 Apr 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK555930/
Gray, S. L., & Semla, T. P. (2019). Post-finasteride syndrome. BMJ (Clinical research ed.), 366, l5047.
https://doi.org/10.1136/bmj.l5047-
Welk, B., McArthur, E., Ordon, M., Anderson, K. K., Hayward, J., & Dixon, S. (2017). Association of Suicidality and Depression With 5α-Reductase Inhibitors. JAMA internal medicine, 177(5), 683–691.
https://doi.org/10.1001/jamainternmed.2017.0089
Irwig M. S. (2020). Finasteride and Suicide: A Postmarketing Case Series. Dermatology (Basel, Switzerland), 236(6), 540–545.
https://doi.org/10.1159/000505151
Żychowska, Magdalena & Batycka-Baran, Aleksandra & Szepietowski, Jacek & Baran, Wojciech. (2016). Dapsone - Mechanism of action, safety of use and the role in the treatment of bullous pemphigoid according to current recommendations. Dermatology Review. 2. 176-184.
https://doi.org/10.5114/dr.2016.59141
Kurien G, Jamil RT, Preuss CV. Dapsone. [Updated 2023 Mar 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470552/
Sago, J., & Hall, R. P. (2002). Dapsone. Dermatologic Therapy, 15(4), 340–351.
https://doi.org/10.1046/j.1529-8019.2002.01543.x
da Silva, C. A. P., Von Kossel, K., Leszczynski, M., Melnik, T., & Riera, R. (2019). Methotrexate for psoriasis. The Cochrane Database of Systematic Reviews, 2019(4), CD010498.
https://doi.org/10.1002/14651858.CD010498.pub2
Liu, M., Huang, Y.Y.M., Hsu, S. et al. Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications. CNS Drugs 30, 1149–1168 (2016). https://doi.org/10.1007/s40263-016-0392-x
Hariram, J., & Jegan, Y. (2013). Contribution of methotrexate in precipitation of manic episode in bipolar affective disorder explored: a case report. Therapeutic advances in psychopharmacology, 3(4), 251–254.
https://doi.org/10.1177/2045125313477103
Uğurer, E., Altunay, İ. K., Özkur, E., & Baltan, E. (2023). The Effects of Methotrexate and Biologics on the Symptoms of Depression and Anxiety in Patients with Psoriasis. Indian journal of dermatology, 68(3), 237–244.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Maria Krzyżanowska, Julia Piątkiewicz, Mateusz Sztybór, Gabriela Nowak, Marcin Kapica, Karol Momot, Mikołaj Wojtas, Karen Głogowska, Monika Maleszewska, Aleksandra Żmijewska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 360
Number of citations: 0
